- Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis - Dec 2014
- People with Autoimmune Hepatitis are 3.2X more likely to die if low Vitamin D – Dec 2024
- VitaminDWiki – Autoimmune category contains
- VitaminDWiki – Vitamin D Receptor is associated in over 58 autoimmune studies
- VitaminDWiki – Overview Liver and vitamin D category contains:
- Autoimmune hepatitis is not caused by a virus the way type A, B, or C are - Perplexity AI Dec 2024
Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis - Dec 2014
Digestive Diseases and Sciences, December 2014, Volume 59, Issue 12, pp 3035-3042
Cumali Efe, Taylan Kav, Cisel Aydin, Mustafa Cengiz, Narin Nasıroglu Imga, Tugrul Purnak, Daniel S. Smyk, Murat Torgutalp, Turan Turhan, Seren Ozenirler
PDF is available free at Sci-Hub 10.1007/s10620-014-3267-3
Background and Aim
25-Hydroxyvitamin D [25(OH)D] has an important role in fibrosis progression and inflammatory response in patients with various etiologies of chronic liver disease. However, its influence on autoimmune hepatitis (AIH) has not been investigated. We evaluated the association of serum 25(OH)D levels with clinical, biochemical and histological features and response to therapy in AIH.
Materials and methods: Serum 25(OH)D levels were quantified in 68 therapy naïve AIH patients and 34 healthy controls.
Results
Mean serum 25(OH)D levels were significantly lower in AIH compared to healthy controls (16.8 ± 9.2 vs. 35.7 ± 13.6, p < 0.0001). Low levels of 25(OH)D (<30 µg/L) were independently associated with advance fibrosis and severe interface hepatitis in AIH patients [p = 0.014; odds ratio (OR) 0.12, 95 % confidence interval (CI) 0.02–0.65 and p = 0.020; OR 0.17, 95 % CI 0.04–0.76, respectively].
Severe 25(OH)D deficiency (<10 µg/L) was associated with
- advance fibrosis,
- severe interface hepatitis,
- low platelet counts and
- sampling time in a univariate analysis.
Only interface hepatitis and fibrosis scores were independently associated with 25(OH)D deficiency in a multiple regression analysis (p = 0.005; OR 0.12, 95 % CI 0.03–0.53 and p = 0.022; OR 0.15, 95 % CI 0.03–0.75, respectively).
Mean serum 25(OH)D levels were lower in non-responders compared to responders (9.2 ± 4.8 vs. 17.1 ± 9.4, p = 0.015), and 25(OH)D deficiency was more commonly observed in non-responders than the responders (80 vs. 43 %, p = 0.036).
Conclusions
Low 25(OH)D levels are associated with advance fibrosis and severe inflammation in AIH. Our study suggests that vitamin D may be a potential biomarker that predicts response to therapy and histological features in AIH.
References
- Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354:54–66. CrossRef
- Vergani D, Longhi MS, Bogdanos DP, et al. Autoimmune hepatitis. Semin Immunopathol. 2009;31:421–435. CrossRef
- Efe C, Ozaslan E, Wahlin S, et al. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. Liver Int. 2013;33:190–196. CrossRef
- Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938. CrossRef
- Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176. CrossRef
- Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–2213. CrossRef
- Liberal R, Longhi MS, Mieli-Vergani G, et al. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25:653–664. CrossRef
- Smyk DS, Orfanidou T, Invernizzi P, et al. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol. 2013;37:535–545. CrossRef
- Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66:1137–1142. CrossRef
- Stokes CS, Volmer DA, Grunhage F, et al. Vitamin D in chronic liver disease. Liver Int. 2013;33:338–352. CrossRef
- Stokes CS, Krawczyk M, Reichel C, et al. Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis. Eur J Clin Invest. 2013. doi:10.1111/eci.12205.
- Dasarathy J, Periyalwar P, Allampati S, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2013. doi:10.1111/liv.12312.
- Petta S, Camma C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51:1158–1167. CrossRef
- Farnik H, Bojunga J, Berger A, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology. 2013;58:1270–1276. CrossRef
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930. CrossRef
- Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–293. CrossRef
- Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology. 2002;35:126–131. CrossRef
- Trépo E, Ouziel R, Pradat P, et al. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. J Hepatol. 2013;59:344–350. CrossRef
- Ma Y, Longhi MS, Bogdanos DP, et al. 17 Functional impairment of CD25+CD4+ regulatory T cells characterizes autoimmune hepatitis type 2. Hepatology. 2003;38:163. CrossRef
- Efe C, Purnak T, Ozaslan E. Anti TNF-alpha therapy can be a novel treatment option in patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2010;32:115. CrossRef
- Weiler-Normann C, Schramm C, Quaas A, et al. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol. 2013;58:529–534. CrossRef
108 citations of Dec 2014 study as of Dec 2024
People with Autoimmune Hepatitis are 3.2X more likely to die if low Vitamin D – Dec 2024
Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective
Aliment Pharmacol Ther. 2024 Dec 11. doi: 10.1111/apt.18438 PDF behind paywall
Yassine Kilani 1, Saqr Alsakarneh 2, Mahmoud Y Madi 3, Daniel Alejandro Gonzalez Mosquera 1, Mariana Nunes Ferreira 1, Fouad Jaber 2, John Helzberg 4, Nikki Duong 5, Wing-Kin Syn 3 6
Background: Vitamin D deficiency is linked to worse outcomes in patients with chronic liver diseases (CLD). However, data in patients with autoimmune hepatitis (AIH) remain limited.
Aims: We aimed to assess the impact of vitamin D deficiency on the outcomes of individuals with AIH.
Methods: This retrospective cohort study used the TriNetX research network to identify patients with AIH. Patients were matched using propensity score matching and stratified to sufficient vitamin D levels (e.g., 25 (OH) D3 ≥ 30 ng/mL), vitamin D insufficiency (25 (OH) D3: 20-29.9 ng/mL) and vitamin D deficiency (e.g., 25 (OH) D3 < 20 ng/mL). The primary outcome was the all-cause mortality among adult patients with AIH. Secondary outcomes included decompensated liver cirrhosis, acute hepatic failure, liver transplantation (LT), all-cause hospitalizations and all-cause critical care admissions.
Results: A total of 1288 AIH patients with vitamin D deficiency were identified and propensity matched with 1288 patients with normal vitamin D levels.
Patients with vitamin D deficiency had significantly increased odds for
- all-cause mortality compared to those with normal levels (adjusted odds ratio (aOR) = 3.2, 95%CI: 2.3-4.48).
Patients with vitamin D deficiency were at increased odds of
- all-cause hospitalizations (aOR = 2.37, 95%CI: 1.97-2.84),
- critical care unit admissions (aOR = 2.8, 95%CI: 2.21-3.71),
- decompensated liver cirrhosis (aOR = 2.74, 95%CI: 2.13-3.54),
- acute hepatic failure (aOR = 3.11, 95%CI: 2.09-4.62) and
- LT (aOR = 3.47, 95%CI: 1.71-7.04), as compared to those with normal vitamin D levels.
Conclusion: This cohort study showed significantly increased odds for all-cause mortality in AIH patients with vitamin D deficiency. Vitamin D deficiency in patients with AIH was associated with increased likelihood of hospitalisation, decompensated liver cirrhosis, acute liver failure and LT.
72 references online
VitaminDWiki – Autoimmune category contains
204 items in Autoimmune category - Vitamin D and MS Asthma RA Diabetes Gut Allergy Hay Fever Lupus Psoriasis
- Predicted 95% autoimmune cured by HIGH-DOSE vitamin D - 2014
- 10% of the UK have Autoimmune Diseases - Lancet May 2023 PDF is behind a paywall
- Increase in 20 years : coeliac disease 2.19 X. Sjogren's syndrome 2.09, and Graves' disease 2.07
- All 43 references are FREE on-line
- Autoimmune diseases fought by Vitamin D, especially if have more than 40 ng – Sept 2022
- The BEST Nutrient for Autoimmune Conditions (Vitamin D) - video May 2022
- The number 1 Deficiency behind All Autoimmune Diseases (Vitamin D) video - Dec 2023
- Autoimmune disease clusters run in families having low D
- How Vitamin D reduces inflammation, improves immunity and fights autoimmunity – review Dec 2018
- 120 doctors and 20,000 MS patients using high dose Vitamin D Dec 2018
- Vitamin D has treated Multiple Sclerosis and autoimmune diseases for 16 years – Coimbra April 2018
- Vitamin D Receptor is associated in over 58 autoimmune studies
- More autoimmune disease if higher pollution or lower UVB - Feb 2023
- Many autoimmune diseases associated with low vitamin D or poor Vit D genes – July 2019
See also web: consensus that ~50 diseases are autoimmune, ~50 more are suspected:
VitaminDWiki – Vitamin D Receptor is associated in over 58 autoimmune studies
VitaminDWiki – Overview Liver and vitamin D category contains:
- Fact: A properly functioning liver is needed for the efficient activation of vitamin D in the body
- Fact: Liver diseases often result in lower levels of vitamin D
- Fact: Various pain relievers damage the liver function
- Fact: Lower levels of vitamin D result in osteoporosis and many other diseases
- Options with a poorly functioning liver appear to be:
- Increased vitamin D (example: 2X more vitamin D if Liver is 1/2 as efficient)
- Increase the response you get from vitamin D
- Increase sunshine / UVB,
- Get the response you get from the sun/UVB
- Consider supplementing with Iron - a patented Iron supplement appears to work very well
- Get prescription for active form of vitamin D (Calcitriol) which does not need the liver or kidney to get the benefits of vitamin D in the body
- Get Calcidiol which does not need the liver
- Use Topical Vitamin D - activation by the skin etc does not require the liver
Click on image for ways of getting vitamin D even if Liver is not functioning well
Autoimmune hepatitis is not caused by a virus the way type A, B, or C are - Perplexity AI Dec 2024
Autoimmune Hepatitis 8X more likely if low vitamin D – Dec 201417814 visitors, last modified 11 Dec, 2024, This page is in the following categories (# of items in each category)Attached files
ID Name Uploaded Size Downloads 10715 Fibrosis scores.jpg admin 20 Oct, 2018 15.02 Kb 1696 10714 hepatitis severity.jpg admin 20 Oct, 2018 14.61 Kb 1258 4612 Autoimmune book.jpg admin 22 Nov, 2014 14.50 Kb 20026